Dishman Carbogen Amcis Ltd.

Financial

	Dishman Carbogen Amc	Sun Pharma Adv. Res	Zenotech Laboratorie
Operational Metrics
API Sector
US DMF Filings	18.0 .	n/a	n/a
Total reactor capacity	1150.0 kL	n/a	n/a
Pharmaceutical Sector
R&D as a % of Total Sales	2.05 %	675.52 %	n/a
Financials
5 yr Average ROE	-0.61 %	-334.23 %	7.83 %
5yr average Equity Multiplier	1.56	4.89	1.26
5yr Average Asset Turnover Ratio	0.25	0.31	0.33
5yr Avg Net Profit Margin	-1.43 %	-251.32 %	-17.58 %
Price to Book	0.57	0.0	3.99
P/E	0.0	0.0	74.54
5yr Avg Cash Conversion Cycle	49.26 Days	116.55 Days	36.89 Days
Inventory Days	106.35 Days	0.0	145.01 Days
Days Receivable	73.33 Days	116.55 Days	61.38 Days
Days Payable	160.45 Days	0.0	477.06 Days
5yr Average Interest Coverage Ratio	1.02	-89.89	-4.03
5yr Avg ROCE	1.2 %	-120.93 %	7.95 %
5yr Avg Operating Profit Margin	15.55 %	-252.66 %	4.66 %
5 yr average Debt to Equity	0.26	0.92	0.12
5yr CAGR Net Profit	n/a	13.74 %	n/a
5yr Average Return on Assets	-0.35 %	-58.27 %	7.07 %
Shareholdings
Promoter Holding	59.32 %	65.67 %	68.84 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-3.42 %	0.0
Change in Mutual Fund Holding (3 Yrs)	-5.69 %	0.77 %	0.0

Business

	Dishman Carbogen Amc	Sun Pharma Adv. Res	Zenotech Laboratorie
Product Wise Break-Up	Product Wise Break-Up Contract Research & Contract Manufacturing (CRAMS) 75.1 API 11.4 Cholesterol & Vit D Analogues 7.4 Quats & Generics 6.1 Marketable Molecules 0 R&D Services 0 Lease rental income 0 Sale of Oncology Products 0 0	Product Wise Break-Up Sale of Oncology Products 0 Marketable Molecules 0 0 Research and Development 100.0 API 0 Quats & Generics 0 Lease rental income 0 0 Cholesterol & Vit D Analogues 0	Product Wise Break-Up Sale of Oncology Products 0 Marketable Molecules 0 0 R&D Services 0 API 0 Quats & Generics 0 Lease rental 9.97 Services- Contract Manufacturing 90.03 Cholesterol & Vit D Analogues 0
Segment Break-Up	Segment Break-Up Carbogen Amcis 39.46 Others 60.54	-	-
Location Wise Break-Up	Location Wise Break-Up Rest of the World 98.29 India 1.71	Location Wise Break-Up India 99.15 Rest of the World 0.85	-
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Non-APIs / Intermediates 31.68 Oncology 20.79 Ophthalmology 17.82 Hormones 13.86 Pain Management 3.96 Blood Related 3.96 Antibiotics 3.96 ADC-Warhead / ADC 3.96 Others 0.01	-	-